Artykuły w czasopismach na temat „P53, 14-3-3”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „P53, 14-3-3”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Mühlmann, Gilbert, Dietmar Öfner, Matthias Zitt, Hannes M. Müller, Hans Maier, Patrizia Moser, Kurt W. Schmid, Marion Zitt i Albert Amberger. "14-3-3 Sigma And p53 Expression in Gastric Cancer and Its Clinical Applications". Disease Markers 29, nr 1 (2010): 21–29. http://dx.doi.org/10.1155/2010/470314.
Pełny tekst źródłaYang, Heng-Yin, Yu-Ye Wen, Chih-Hsin Chen, Guillermina Lozano i Mong-Hong Lee. "14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth". Molecular and Cellular Biology 23, nr 20 (15.10.2003): 7096–107. http://dx.doi.org/10.1128/mcb.23.20.7096-7107.2003.
Pełny tekst źródłaCHEN, DE-YU, DONG-FANG DAI, YE HUA i WEN-QING QI. "p53 suppresses 14-3-3γ by stimulating proteasome-mediated 14-3-3γ protein degradation". International Journal of Oncology 46, nr 2 (7.11.2014): 818–24. http://dx.doi.org/10.3892/ijo.2014.2740.
Pełny tekst źródłaDoveston, Richard G., Ave Kuusk, Sebastian A. Andrei, Seppe Leysen, Qing Cao, Maria P. Castaldi, Adam Hendricks i in. "Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction". FEBS Letters 591, nr 16 (sierpień 2017): 2449–57. http://dx.doi.org/10.1002/1873-3468.12723.
Pełny tekst źródłaRawlinson, Imogen, Carol McMenemy i David Greenhalgh. "P19 Inducible 14-3-3 sigma/stratifin ablation accelerates malignant progression in HK1.ras/fos-Δ5PTENflx transgenic mouse skin carcinogenesis". British Journal of Dermatology 189, nr 1 (lipiec 2023): e21-e21. http://dx.doi.org/10.1093/bjd/ljad174.040.
Pełny tekst źródłaYang, Wensheng, David T. Dicker, Jiandong Chen i Wafik S. El-Deiry. "CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2". Cell Cycle 7, nr 5 (marzec 2008): 670–82. http://dx.doi.org/10.4161/cc.7.5.5701.
Pełny tekst źródłaRajagopalan, Sridharan, Robert S. Sade, Fiona M. Townsley i Alan R. Fersht. "Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms". Nucleic Acids Research 38, nr 3 (20.11.2009): 893–906. http://dx.doi.org/10.1093/nar/gkp1041.
Pełny tekst źródłaSchumacher, Benjamin, Justine Mondry, Philipp Thiel, Michael Weyand i Christian Ottmann. "Structure of the p53 C-terminus bound to 14-3-3: Implications for stabilization of the p53 tetramer". FEBS Letters 584, nr 8 (3.03.2010): 1443–48. http://dx.doi.org/10.1016/j.febslet.2010.02.065.
Pełny tekst źródłaWaterman, Matthew J. F., Elena S. Stavridi, Jennifer L. F. Waterman i Thanos D. Halazonetis. "ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins". Nature Genetics 19, nr 2 (czerwiec 1998): 175–78. http://dx.doi.org/10.1038/542.
Pełny tekst źródłaMontano, Ximena. "Common amino acid sequence motifs in p53, 14-3-3 and Akt protein families". FEBS Letters 507, nr 2 (18.10.2001): 237–40. http://dx.doi.org/10.1016/s0014-5793(01)02903-9.
Pełny tekst źródłaLee, Mong-Hong, i Guillermina Lozano. "Regulation of the p53-MDM2 pathway by 14-3-3 σ and other proteins". Seminars in Cancer Biology 16, nr 3 (czerwiec 2006): 225–34. http://dx.doi.org/10.1016/j.semcancer.2006.03.009.
Pełny tekst źródłaHardman-Carter, Rebecca, Revvekka Lefkati, Carol McMenemy i David Greenhalgh. "P10 Inducible 14-3-3 sigma/stratifin ablation cooperates with rasHa activation to accelerate papillomatogenesis and induce malignant conversion in transgenic mouse skin carcinogenesis". British Journal of Dermatology 189, nr 1 (lipiec 2023): e17-e18. http://dx.doi.org/10.1093/bjd/ljad174.032.
Pełny tekst źródłaAktary, Z., S. Kulak, J. Mackey, N. Jahroudi i M. Pasdar. "Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3". Journal of Cell Science 126, nr 14 (17.05.2013): 3031–42. http://dx.doi.org/10.1242/jcs.120642.
Pełny tekst źródłaRajagopalan, S., A. M. Jaulent, M. Wells, D. B. Veprintsev i A. R. Fersht. "14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers". Nucleic Acids Research 36, nr 18 (6.09.2008): 5983–91. http://dx.doi.org/10.1093/nar/gkn598.
Pełny tekst źródłaJin, Yun-Hye, Yeon-Jin Kim, Dae-Won Kim, Kwang-Hyun Baek, Bok Yun Kang, Chang-Yeol Yeo i Kwang-Youl Lee. "Sirt2 interacts with 14-3-3 β/γ and down-regulates the activity of p53". Biochemical and Biophysical Research Communications 368, nr 3 (kwiecień 2008): 690–95. http://dx.doi.org/10.1016/j.bbrc.2008.01.114.
Pełny tekst źródłaOkamoto, Koji, Kenji Kashima, Yaron Pereg, Michiko Ishida, Satomi Yamazaki, Ayumi Nota, Amina Teunisse i in. "DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation". Molecular and Cellular Biology 25, nr 21 (1.11.2005): 9608–20. http://dx.doi.org/10.1128/mcb.25.21.9608-9620.2005.
Pełny tekst źródłaChan, Timothy A., Paul M. Hwang, Heiko Hermeking, Kenneth W. Kinzler i Bert Vogelstein. "Cooperative effects of genes controlling the G2/M checkpoint". Genes & Development 14, nr 13 (1.07.2000): 1584–88. http://dx.doi.org/10.1101/gad.14.13.1584.
Pełny tekst źródłaMuñoz-Fontela, Cesar, Laura Marcos-Villar, Pedro Gallego, Javier Arroyo, Marco Da Costa, Karen M. Pomeranz, Eric W. F. Lam i Carmen Rivas. "Latent Protein LANA2 from Kaposi's Sarcoma-Associated Herpesvirus Interacts with 14-3-3 Proteins and Inhibits FOXO3a Transcription Factor". Journal of Virology 81, nr 3 (15.11.2006): 1511–16. http://dx.doi.org/10.1128/jvi.01816-06.
Pełny tekst źródłaKuusk, Ave, Helen Boyd, Hongming Chen i Christian Ottmann. "Small-molecule modulation of p53 protein-protein interactions". Biological Chemistry 401, nr 8 (28.07.2020): 921–31. http://dx.doi.org/10.1515/hsz-2019-0405.
Pełny tekst źródłaLee, Jun-Ho, i Hua Lu. "14-3-3γ Inhibition of MDMX-mediated p21 Turnover Independent of p53". Journal of Biological Chemistry 286, nr 7 (9.12.2010): 5136–42. http://dx.doi.org/10.1074/jbc.m110.190470.
Pełny tekst źródłaYang, Huiling, Ruiying Zhao i Mong-Hong Lee. "14-3-3σ, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma". Molecular Cancer Therapeutics 5, nr 2 (luty 2006): 253–60. http://dx.doi.org/10.1158/1535-7163.mct-05-0395.
Pełny tekst źródłaHermeking, Heiko, Christoph Lengauer, Kornelia Polyak, Tong-Chuan He, Lin Zhang, Sam Thiagalingam, Kenneth W. Kinzler i Bert Vogelstein. "14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression". Molecular Cell 1, nr 1 (grudzień 1997): 3–11. http://dx.doi.org/10.1016/s1097-2765(00)80002-7.
Pełny tekst źródłaLiu, Nan, Hongli Yang i Liangui Yang. "Modeling the roles of 14-3-3 σ and Wip1 in p53 dynamics and programmed cell death*". Communications in Theoretical Physics 73, nr 8 (21.06.2021): 085602. http://dx.doi.org/10.1088/1572-9494/abfd2a.
Pełny tekst źródłaWang, Moyu, Hongmei Li, Xiyu Sun, Jianhua Qiu, Changhua Jing, Huiyue Jia, Yujie Guo i Huijun Guo. "J Subgroup Avian Leukosis Virus Strain Promotes Cell Proliferation by Negatively Regulating 14-3-3σ Expressions in Chicken Fibroblast Cells". Viruses 15, nr 2 (31.01.2023): 404. http://dx.doi.org/10.3390/v15020404.
Pełny tekst źródłaOhtani, Shoichiro, Shunsuke Kagawa, Yasuhisa Tango, Tatsuo Umeoka, Naoyuki Tokunaga, Yousuke Tsunemitsu, Jack A. Roth, Yoichi Taya, Noriaki Tanaka i Toshiyoshi Fujiwara. "Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo". Molecular Cancer Therapeutics 3, nr 1 (1.01.2004): 93–100. http://dx.doi.org/10.1158/1535-7163.93.3.1.
Pełny tekst źródłaPereg, Yaron, Suzanne Lam, Amina Teunisse, Sharon Biton, Erik Meulmeester, Leonid Mittelman, Giacomo Buscemi i in. "Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage". Molecular and Cellular Biology 26, nr 18 (15.09.2006): 6819–31. http://dx.doi.org/10.1128/mcb.00562-06.
Pełny tekst źródłaOldfield, Christopher J., Jingwei Meng, Jack Y. Yang, Mary Qu Yang, Vladimir N. Uversky i A. Keith Dunker. "Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners". BMC Genomics 9, Suppl 1 (2008): S1. http://dx.doi.org/10.1186/1471-2164-9-s1-s1.
Pełny tekst źródłaSchumacher, Benjamin, Justine Mondry, Philipp Thiel, Michael Weyand i Christian Ottmann. "Binary complex of 14-3-3σ/p53 pT387-peptide and implications for stabilization". Acta Crystallographica Section A Foundations of Crystallography 66, a1 (29.08.2010): s148—s149. http://dx.doi.org/10.1107/s0108767310096698.
Pełny tekst źródłaBrownlee, Noel A., L. Allen Perkins, Will Stewart, Beth Jackle, Mark J. Pettenati, Patrick P. Koty, Samy S. Iskandar i A. Julian Garvin. "Recurring Translocation (10;17) and Deletion (14q) in Clear Cell Sarcoma of the Kidney". Archives of Pathology & Laboratory Medicine 131, nr 3 (1.03.2007): 446–51. http://dx.doi.org/10.5858/2007-131-446-rtadqi.
Pełny tekst źródłaGu, Yanyan, Jonathan L. Kaufman, Lawrence H. Boise i Sagar Lonial. "Validation of the Function of 14-3-3 ζ in Multiple Myeloma (MM)". Blood 118, nr 21 (18.11.2011): 1369. http://dx.doi.org/10.1182/blood.v118.21.1369.1369.
Pełny tekst źródłaNagappan, Arulkumar, Hyeon Soo Park, Kwang Il Park, Gyeong Eun Hong, Silvia Yumnam, Ho Jeong Lee, Mun Ki Kim i in. "Helicobacter pylori infection combined with DENA revealed altered expression of p53 and 14-3-3 isoforms in Gulo−/− mice". Chemico-Biological Interactions 206, nr 2 (listopad 2013): 143–52. http://dx.doi.org/10.1016/j.cbi.2013.09.002.
Pełny tekst źródłaBenzinger, Anne, Nemone Muster, Heike B. Koch, John R. Yates i Heiko Hermeking. "Targeted Proteomic Analysis of 14-3-3ς, a p53 Effector Commonly Silenced in Cancer". Molecular & Cellular Proteomics 4, nr 6 (18.03.2005): 785–95. http://dx.doi.org/10.1074/mcp.m500021-mcp200.
Pełny tekst źródłaDanes, Christopher G., Shannon L. Wyszomierski, Jing Lu, Christopher L. Neal, Wentao Yang i Dihua Yu. "14-3-3ζ Down-regulates p53 in Mammary Epithelial Cells and Confers Luminal Filling". Cancer Research 68, nr 6 (13.03.2008): 1760–67. http://dx.doi.org/10.1158/0008-5472.can-07-3177.
Pełny tekst źródłaLee, Ming Kei, i Kanaga Sabapathy. "Phosphorylation at Carboxyl-Terminal S373 and S375 Residues and 14-3-3 Binding Are Not Required for Mouse p53 Function". Neoplasia 9, nr 9 (wrzesień 2007): 690–98. http://dx.doi.org/10.1593/neo.07511.
Pełny tekst źródłaZhang, Bo, Bo Zhou, Guihong Huang, Jing'an Huang, Xiaoxin Lin, Zonghuai Li, Yuanchu Lian, Qiujie Huang i Yong Ye. "Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment". Heliyon 10, nr 1 (styczeń 2024): e24012. http://dx.doi.org/10.1016/j.heliyon.2024.e24012.
Pełny tekst źródłaWu, Qiao, Hua Fan, Ren Lang, Xianliang Li, Xingmao Zhang, Shaocheng Lv i Qiang He. "Overexpression of 14-3-3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling". BioMed Research International 2020 (23.06.2020): 1–9. http://dx.doi.org/10.1155/2020/3740418.
Pełny tekst źródłaTolcher, Anthony W., Desiree Hao, Johann de Bono, Alex Miller, Amita Patnaik, Lisa A. Hammond, Leslie Smetzer i in. "Phase I, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered Ad5CMV-p53, an Adenoviral Vector Containing the Wild-Type p53 Gene, in Patients With Advanced Cancer". Journal of Clinical Oncology 24, nr 13 (1.05.2006): 2052–58. http://dx.doi.org/10.1200/jco.2005.03.6756.
Pełny tekst źródłaZhang, Yiwei, Yitian Zha i Hua Lu. "Abstract 2377: Impairment of p53-activating pathways accelerates liver cancer initiation partially through MTHFD1L-mediated 1C metabolism". Cancer Research 82, nr 12_Supplement (15.06.2022): 2377. http://dx.doi.org/10.1158/1538-7445.am2022-2377.
Pełny tekst źródłaSharma, Balkrishan, Duaa Mureb, Sumit Murab, Leah A. Rosenfeldt, Brenton J. Francisco, Alexander A. Boucher, Rachel Cantrell i in. "Fibrinogen Activates FAK to Promote the Colorectal Adenocarcinoma Growth". Blood 134, Supplement_1 (13.11.2019): 1111. http://dx.doi.org/10.1182/blood-2019-130497.
Pełny tekst źródłaTabe, Yoko, Yasushi Isobe, Koichi Sugimoto, Linhua Jin, Kazuo Oshimi i Takashi Miida. "The MDM2 Antagonist Nutlin-3 Is Effective to Aggressive NK-Cell Neoplasms with Wild Type p53 in Hypoxia". Blood 118, nr 21 (18.11.2011): 4999. http://dx.doi.org/10.1182/blood.v118.21.4999.4999.
Pełny tekst źródłaNarasimhan, Sudha Rani, Lin Yang, Brenda I. Gerwin i V. Courtney Broaddus. "Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax". American Journal of Physiology-Lung Cellular and Molecular Physiology 275, nr 1 (1.07.1998): L165—L171. http://dx.doi.org/10.1152/ajplung.1998.275.1.l165.
Pełny tekst źródłaWu, Shin-Hwar, Tzu-Yun Wu, Yung-Ting Hsiao, Ju-Hwa Lin, Shu-Chun Hsu, Te-Chun Hsia, Su-Tso Yang, Wu-Huei Hsu i Jing-Gung Chung. "Bufalin Induces Cell Death in Human Lung Cancer Cells through Disruption of DNA Damage Response Pathways". American Journal of Chinese Medicine 42, nr 03 (styczeń 2014): 729–42. http://dx.doi.org/10.1142/s0192415x14500475.
Pełny tekst źródłaNunun, Somrudee, Paramee Thongsuksai, Keson Trakunrum i Pritsana Raungrut. "Down-Regulation of 14-3-3σ Reduces Proliferation of Human Lung Cancers But Not Colon Cancer Cells". Journal of Health Science and Medical Research 36, nr 2 (24.05.2018): 97. http://dx.doi.org/10.31584/jhsmr.2018.36.2.3.
Pełny tekst źródłaNunun, Somrudee, Paramee Thongsuksai, Keson Trakunrum i Pritsana Raungrut. "Down-Regulation of 14-3-3σ Reduces Proliferation of Human Lung Cancers But Not Colon Cancer Cells". Journal of Health Science and Medical Research 36, nr 2 (24.05.2018): 97. http://dx.doi.org/10.31584/jhsmr.v36i2.3.
Pełny tekst źródłaHuang, Sheng-Yen, Min-Jie Hsieh, Chu-Ying Chen, Yen-Ju Chen, Jen-Yang Chen, Mei-Ru Chen, Ching-Hwa Tsai, Su-Fang Lin i Tsuey-Ying Hsu. "Epstein–Barr virus Rta-mediated transactivation of p21 and 14-3-3σ arrests cells at the G1/S transition by reducing cyclin E/CDK2 activity". Journal of General Virology 93, nr 1 (1.01.2012): 139–49. http://dx.doi.org/10.1099/vir.0.034405-0.
Pełny tekst źródłaSzkaradkiewicz, Andrzej, Tomasz Karpiński, Jan Majewski, Kamila Malinowska, Olga Goślińska-Kuźniarek i Krzysztof Linke. "The Participation of p53 and bcl-2 Proteins in Gastric Carcinomas Associated with Helicobacter pylori and/or Epstein-Barr Virus (EBV)". Polish Journal of Microbiology 64, nr 3 (18.09.2015): 211–16. http://dx.doi.org/10.5604/01.3001.0009.2116.
Pełny tekst źródłaWestfall, Matthew D., Deborah J. Mays, Joseph C. Sniezek i Jennifer A. Pietenpol. "The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations". Molecular and Cellular Biology 23, nr 7 (1.04.2003): 2264–76. http://dx.doi.org/10.1128/mcb.23.7.2264-2276.2003.
Pełny tekst źródłaLi, Honghui, Wenmin Cheng, Bowei Chen, Shaoxia Pu, Ninglin Fan, Xiaolin Zhang, Deling Jiao i in. "Efficient Generation of P53 Biallelic Mutations in Diannan Miniature Pigs Using RNA-Guided Base Editing". Life 11, nr 12 (17.12.2021): 1417. http://dx.doi.org/10.3390/life11121417.
Pełny tekst źródłaMartínez-Galán, Joaquina, Cynthia S. González Rivas, Julia Ruiz Vozmediano, Pedro Ballesteros, Juan Ramón Delgado, Sandra Ríos, M. Isabel Núñez, Jesus Lopez-Peñalver i Blanca Torres-Torres. "Implications prognostics of methylation 14-3-3 sigma promoter in peripheral blood cell DNA with nodal involvement status and tumor size for breast cancer patients." Journal of Clinical Oncology 30, nr 27_suppl (20.09.2012): 33. http://dx.doi.org/10.1200/jco.2012.30.27_suppl.33.
Pełny tekst źródłaMaurya, Rajendra Prakash, Sanjay Kumar Bosak, Royana Singh, Virendra Pratap Singh, Samer Singh, Per O. Lundmark, Shivangi Singh, Anil Kumar i Tanmay Srivastav. "Analysis of tumor protein p53 (p53) mutations in eyelid malignancy". IP International Journal of Ocular Oncology and Oculoplasty 7, nr 3 (15.10.2021): 243–49. http://dx.doi.org/10.18231/j.ijooo.2021.051.
Pełny tekst źródła